(SLQT) Selectquote - Ratings and Ratios
Insurance, Healthcare, Life, Auto, Home
SLQT EPS (Earnings per Share)
SLQT Revenue
Description: SLQT Selectquote
SelectQuote, Inc. (NYSE:SLQT) is a technology-enabled insurance distribution platform that operates in the United States, offering a range of insurance policies and healthcare services directly to consumers. The company is segmented into four main business areas: Senior, Healthcare Services, Life, and Auto & Home, providing a diverse portfolio of products including medicare advantage, life insurance, and property & casualty insurance.
Key aspects of SelectQuotes business include its distribution capabilities, product offerings, and services such as SelectRx, a patient-centered pharmacy that provides medication management and therapy services. The companys ability to contract with insurance carriers and provide population health services helps members understand their health plan benefits. With a presence in the US insurance market, SelectQuotes performance can be evaluated using key performance indicators (KPIs) such as revenue growth, customer acquisition costs, and policy retention rates.
Notable KPIs for SelectQuote include its ability to generate revenue through commission-based sales, its expense management, and its capacity to adapt to changing regulatory environments. The companys return on equity (RoE) is currently negative, indicating that it may be investing heavily in growth initiatives. Other relevant metrics could include the companys operating margin, debt-to-equity ratio, and the growth rate of its various business segments.
To further analyze SelectQuotes prospects, one could examine industry trends, competitive positioning, and the companys technological capabilities. The insurance distribution landscape is highly competitive, and SelectQuotes success will depend on its ability to innovate, manage risk, and expand its customer base. By monitoring KPIs such as customer lifetime value, sales productivity, and market share, investors can gain insights into the companys potential for long-term growth and profitability.
SLQT Stock Overview
| Market Cap in USD | 373m |
| Sub-Industry | Property & Casualty Insurance |
| IPO / Inception | 2020-05-21 |
SLQT Stock Ratings
| Growth Rating | 12.3% |
| Fundamental | 60.7% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -16.9% |
| Analyst Rating | 4.0 of 5 |
SLQT Dividends
Currently no dividends paidSLQT Growth Ratios
| Growth Correlation 3m | -35.7% |
| Growth Correlation 12m | -19.2% |
| Growth Correlation 5y | -47.2% |
| CAGR 5y | 17.60% |
| CAGR/Max DD 3y | 0.25 |
| CAGR/Mean DD 3y | 0.42 |
| Sharpe Ratio 12m | -1.42 |
| Alpha | 0.11 |
| Beta | 0.718 |
| Volatility | 83.65% |
| Current Volume | 791k |
| Average Volume 20d | 1258.8k |
| Stop Loss | 1.8 (-11.8%) |
| Signal | -0.36 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (47.6m TTM) > 0 and > 6% of Revenue (6% = 91.6m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -1.17pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 8.39% (prev 11.98%; Δ -3.59pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -11.7m <= Net Income 47.6m (YES >=105%, WARN >=100%) |
| Net Debt (63.6m) to EBITDA (109.4m) ratio: 0.58 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.60 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (184.2m) change vs 12m ago 9.31% (target <= -2.0% for YES) |
| Gross Margin 61.30% (prev 51.60%; Δ 9.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 114.0% (prev 110.7%; Δ 3.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.14 (EBITDA TTM 109.4m / Interest Expense TTM 78.1m) >= 6 (WARN >= 3) |
Altman Z'' 0.27
| (A) 0.09 = (Total Current Assets 341.0m - Total Current Liabilities 212.9m) / Total Assets 1.49b |
| (B) -0.15 = Retained Earnings (Balance) -222.2m / Total Assets 1.49b |
| (C) 0.07 = EBIT TTM 88.9m / Avg Total Assets 1.34b |
| (D) -0.24 = Book Value of Equity -220.5m / Total Liabilities 909.8m |
| Total Rating: 0.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.72
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield -1.89% = -0.95 |
| 3. FCF Margin -0.91% = -0.34 |
| 4. Debt/Equity 0.69 = 2.27 |
| 5. Debt/Ebitda 3.61 = -2.38 |
| 6. ROIC - WACC (= 4.46)% = 5.57 |
| 7. RoE 11.01% = 0.92 |
| 8. Rev. Trend 66.49% = 4.99 |
| 9. EPS Trend 22.76% = 1.14 |
What is the price of SLQT shares?
Over the past week, the price has changed by +4.08%, over one month by +2.00%, over three months by -6.85% and over the past year by -1.45%.
Is Selectquote a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SLQT is around 1.73 USD . This means that SLQT is currently overvalued and has a potential downside of -15.2%.
Is SLQT a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SLQT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.3 | 157.4% |
| Analysts Target Price | 5.3 | 157.4% |
| ValueRay Target Price | 1.9 | -7.8% |
Last update: 2025-09-04 02:51
SLQT Fundamental Data Overview
CCE Cash And Equivalents = 35.7m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 216.0
P/E Forward = 66.6667
P/S = 0.2445
P/B = 1.1123
Beta = 1.214
Revenue TTM = 1.53b USD
EBIT TTM = 88.9m USD
EBITDA TTM = 109.4m USD
Long Term Debt = 316.6m USD (from longTermDebt, last quarter)
Short Term Debt = 78.2m USD (from shortTermDebt, last quarter)
Debt = 394.8m USD (Calculated: Short Term 78.2m + Long Term 316.6m)
Net Debt = 63.6m USD (from netDebt column, last quarter)
Enterprise Value = 732.3m USD (373.3m + Debt 394.8m - CCE 35.7m)
Interest Coverage Ratio = 1.14 (Ebit TTM 88.9m / Interest Expense TTM 78.1m)
FCF Yield = -1.89% (FCF TTM -13.9m / Enterprise Value 732.3m)
FCF Margin = -0.91% (FCF TTM -13.9m / Revenue TTM 1.53b)
Net Margin = 3.12% (Net Income TTM 47.6m / Revenue TTM 1.53b)
Gross Margin = 61.30% ((Revenue TTM 1.53b - Cost of Revenue TTM 590.9m) / Revenue TTM)
Tobins Q-Ratio = -3.32 (set to none) (Enterprise Value 732.3m / Book Value Of Equity -220.5m)
Interest Expense / Debt = 2.77% (Interest Expense 10.9m / Debt 394.8m)
Taxrate = 1.92% (931.0k / 48.5m)
NOPAT = 87.2m (EBIT 88.9m * (1 - 1.92%))
Current Ratio = 1.60 (Total Current Assets 341.0m / Total Current Liabilities 212.9m)
Debt / Equity = 0.69 (Debt 394.8m / last Quarter total Stockholder Equity 575.5m)
Debt / EBITDA = 3.61 (Net Debt 63.6m / EBITDA 109.4m)
Debt / FCF = -28.49 (Debt 394.8m / FCF TTM -13.9m)
Total Stockholder Equity = 432.2m (last 4 quarters mean)
RoA = 3.20% (Net Income 47.6m, Total Assets 1.49b )
RoE = 11.01% (Net Income TTM 47.6m / Total Stockholder Equity 432.2m)
RoCE = 11.87% (Ebit 88.9m / (Equity 432.2m + L.T.Debt 316.6m))
RoIC = 10.06% (NOPAT 87.2m / Invested Capital 866.4m)
WACC = 5.60% (E(373.3m)/V(768.0m) * Re(8.66%)) + (D(394.8m)/V(768.0m) * Rd(2.77%) * (1-Tc(0.02)))
Shares Correlation 3-Years: 75.99 | Cagr: 1.02%
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -13.9m)
EPS Correlation: 22.76 | EPS CAGR: 94.35% | SUE: 1.63 | # QB: 1
Revenue Correlation: 66.49 | Revenue CAGR: 31.51% | SUE: 0.0 | # QB: 0
Additional Sources for SLQT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle